Survival, local control, and health-related quality of life in patients with oligometastatic and polymetastatic spinal tumors: A multicenter, international study Academic Article uri icon

Overview

MeSH Major

  • Neoplasm Recurrence, Local
  • Radiotherapy, Intensity-Modulated
  • Spinal Neoplasms

abstract

  • The treatment of oligometastatic disease appears to offer a significant survival advantage compared with polymetastatic disease, regardless of treatment choice. HRQOL measures were found to improve in both groups, demonstrating a palliative benefit for all treated patients.

publication date

  • March 2019

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.31870

PubMed ID

  • 30489634

Additional Document Info

start page

  • 770

end page

  • 778

volume

  • 125

number

  • 5